CJC-1295 stays in your system for roughly 6 to 11 days after a single injection, depending on the version you use. The version with DAC (Drug Affinity Complex) has an estimated half-life of 5.8 to 8.1 days, meaning it takes well over a week for the peptide itself to clear. The version without DAC is much shorter-acting, remaining active for only several hours after injection. But the downstream hormonal effects of either version last considerably longer than the peptide itself.
Half-Life of CJC-1295 With DAC
The DAC version of CJC-1295 has a half-life between 5.8 and 8.1 days. A drug is generally considered cleared from your body after four to five half-lives, which puts total clearance somewhere around 23 to 40 days after a single dose. That extended presence in the bloodstream is the entire point of the DAC modification: it allows the peptide to bind to albumin, a protein naturally circulating in your blood, which shields it from being broken down quickly.
After a single injection, growth hormone levels rise by 2- to 10-fold and stay elevated for six days or more. IGF-1 levels, a secondary marker that reflects sustained growth hormone activity, climb 1.5- to 3-fold above baseline and remain elevated for 9 to 11 days. So even after the peptide concentration drops below detectable levels, its biological footprint lingers in the form of elevated IGF-1.
Half-Life of CJC-1295 Without DAC
CJC-1295 without DAC (sometimes called modified GRF 1-29 or “mod GRF”) behaves very differently. It remains active for several hours rather than days, putting it much closer to older growth hormone-releasing peptides in terms of duration. Without the albumin-binding modification, your body breaks it down rapidly.
For comparison, sermorelin, a first-generation peptide in the same class, has a half-life of just 10 to 20 minutes. The non-DAC version of CJC-1295 sits between sermorelin and the DAC version: longer than minutes, but far shorter than days. This is why the non-DAC form typically requires multiple daily injections to maintain any meaningful elevation in growth hormone.
Cumulative Effects With Repeated Doses
If you’ve been using CJC-1295 with DAC over multiple weeks, clearance takes longer than it would after a single injection. Clinical data show a cumulative effect: after multiple doses, IGF-1 levels remained above baseline for up to 28 days. That means roughly a month of measurable hormonal impact after your last injection, even though the peptide itself may be undetectable well before that point.
This distinction matters. “How long it stays in your system” has two answers. The peptide compound itself clears within a few weeks. But the hormonal changes it triggers, particularly the sustained IGF-1 elevation, persist for up to four weeks after the final dose of a multi-injection course. If you’re concerned about drug testing or timing around a medical procedure, the longer window is the one that matters.
How CJC-1295 Is Broken Down
CJC-1295 with DAC works by covalently binding to albumin after subcutaneous injection. This isn’t a loose association; the peptide chemically attaches to albumin molecules already circulating in your blood. Because albumin has its own long half-life (roughly 19 to 21 days in humans), the attached peptide essentially hitches a ride, avoiding the rapid enzymatic breakdown that destroys most peptides within minutes.
Animal studies illustrate the timeline well. In rats, a single injection of CJC-1295 produced peak growth hormone output within the first two hours, with a mean residence time in plasma exceeding 30 hours and detectable levels still present at 72 hours. In humans, the effect scales up significantly due to the longer half-life of human albumin and slower metabolic rate relative to body size.
What This Means for Detection
Standard blood panels don’t test for CJC-1295 directly, but anti-doping and specialized peptide screens can identify it. Given the 5.8- to 8.1-day half-life of the DAC version, trace amounts could theoretically be detectable for three to five weeks after a single injection. After repeated dosing, that window extends further due to accumulation.
The non-DAC version clears much faster and would be far harder to detect beyond 24 to 48 hours, though its metabolic byproducts and the resulting growth hormone and IGF-1 elevations could still raise flags on a hormone panel for several days. IGF-1 levels specifically can stay elevated for over a week even from the shorter-acting form, since IGF-1 reflects cumulative growth hormone exposure rather than the presence of the peptide itself.